0001787792-26-000003.txt : 20260304
0001787792-26-000003.hdr.sgml : 20260304
20260304120217
ACCESSION NUMBER: 0001787792-26-000003
CONFORMED SUBMISSION TYPE: C-U
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20260304
DATE AS OF CHANGE: 20260304
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Fisher Wallace Laboratories, Inc.
CENTRAL INDEX KEY: 0001787792
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
EIN: 208131183
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: C-U
SEC ACT: 1933 Act
SEC FILE NUMBER: 020-36769
FILM NUMBER: 26719786
BUSINESS ADDRESS:
STREET 1: 515 MADISON AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: 917-930-4332
MAIL ADDRESS:
STREET 1: 630 FLUSHING AVENUE, BOX 104
CITY: BROOKLYN
STATE: NY
ZIP: 11206
C-U
1
primary_doc.xml
C-U
0001787792
XXXXXXXX
020-36769
LIVE
false
false
false
The Offering ended on February 20, 2026, having closed on $127,683.74 of funds although final accounting has yet to take place.
Fisher Wallace Laboratories, Inc.
Corporation
DE
08-23-2019
630 FLUSHING AVENUE, BOX 104
BROOKLYN
NY
11206
fisherwallace.com
N
DEALMAKER SECURITIES LLC
0001872856
008-70756
000315324
Up to 8.5%
Common Stock
8921
11.21000
103504.56
Y
Other
At the discretion of the Company
2587498.09
02-20-2026
5.00
154382.00
361017.00
41626.00
311160.00
0.00
0.00
596720.00
569243.00
940656.00
866830.00
47412.00
2019527.00
3012.00
350736.00
0.00
0.00
-1579900.00
-1644382.00
AL
AK
AZ
AR
CA
CO
CT
DE
DC
FL
GA
HI
ID
IL
IN
IA
KS
KY
LA
ME
MD
MA
MI
MN
MS
MO
MT
NE
NV
NH
NJ
NM
NY
NC
ND
OH
OK
OR
PA
PR
RI
SC
SD
TN
TX
UT
VT
VA
WA
WV
WI
WY
A0
A1
A2
A3
A4
A5
A6
A7
A8
A9
B0
Z4
Fisher Wallace Laboratories, Inc.
/Kelly Roman/
Chief Executive Officer and Director
/Kelly Roman/
Chief Executive Officer and Director
03-04-2026